Enhancement by 1 alpha,25-dihydroxyvitamin D3 of chemically induced transformation of BALB 3T3 cells without induction of ornithine decarboxylase or activation of protein kinase C1.

Abstract:

:We reported previously that 1 alpha,25-dihydroxyvitamin D3 [1 alpha,25(OH)2D3], a hormonally active form of vitamin D3, markedly enhanced methylcholanthrene-induced transformation of BALB 3T3 A31-1-1 cells. When the cells were treated with methylcholanthrene (1 microgram/ml) for 72 h and then with 1 alpha,25(OH)2D3 (5 ng/ml) for 2 wk, the transformation frequency was 1.95 +/- 0.73 (SD) foci/dish in 8 independent experiments, which was about 20 times that in cultures treated with methylcholanthrene only. Even at a physiological concentration in plasma, i.e., 0.05 ng/ml, 1 alpha,25(OH)2D3 enhanced the transformation frequency significantly (P less than 0.001). 1 alpha,25(OH)2D3 was not cytotoxic but slightly inhibited growth of the cells. Cells treated with 1 alpha,25(OH)2D3 were thin and became arranged in a meshwork with wide intercellular spaces. These morphological changes were reversible. 1 alpha,25(OH)2D3 induced DNA synthesis in quiescent BALB 3T3 cells dose and time dependently, but this effect was less than that of 12-O-tetradecanoylphorbol-13-acetate. Unlike 12-O-tetradecanoylphorbol-13-acetate, 1 alpha,25(OH)2D3 did not interfere with the binding of epidermal growth factor or phorbol dibutyrate. 1 alpha,25(OH)2D3 did not induce ornithine decarboxylase. Moreover, it did not activate protein kinase C in quiescent BALB 3T3 cells or this enzyme isolated from mouse brain. BALB 3T3 cells and their transformants contain a specific cytosol receptor for 1 alpha,25(OH)2D3, but the binding sites of the transformants were fewer and had lower affinity than those of untransformed BALB 3T3 cells. These effects of 1 alpha,25(OH)2D3 were specific, because other derivatives of vitamin D3 induced the same effects only at 200 times or more higher concentrations.

journal_name

Cancer Res

journal_title

Cancer research

authors

Sasaki K,Chida K,Hashiba H,Kamata N,Abe E,Suda T,Kuroki T

subject

Has Abstract

pub_date

1986-02-01 00:00:00

pages

604-10

issue

2

eissn

0008-5472

issn

1538-7445

journal_volume

46

pub_type

杂志文章
  • Involvement of protein kinase C in the regulation of glycolipid sulfotransferase activity levels in renal cell carcinoma cells.

    abstract::Accumulation of sulfolipids associated with elevated levels of glycolipid sulfotransferase activities has previously been demonstrated in renal cell carcinoma cells. To investigate the role of protein kinase C in the synthesis of sulfolipids, the effects of 12-O-tetradecanoylphorbol-13-acetate and protein kinase C inh...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kobayashi T,Honke K,Gasa S,Sugiura M,Miyazaki T,Ishizuka I,Makita A

    更新日期:1993-06-01 00:00:00

  • MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.

    abstract::MicroRNAs (miRNA) are a recently discovered class of noncoding RNAs that negatively regulate gene expression. Recent evidence indicates that miRNAs may play an important role in cancer. However, the mechanism of their deregulation in neoplastic transformation has only begun to be understood. To elucidate the role of t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-1585

    authors: Corney DC,Flesken-Nikitin A,Godwin AK,Wang W,Nikitin AY

    更新日期:2007-09-15 00:00:00

  • Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer via Its Promotion of Intratumoral Androgen Biosynthesis.

    abstract::Targeting of steroidogenic enzymes (e.g., abiraterone acetate targeting CYP17A1) has been developed as a novel therapeutic strategy against metastatic castration-resistant prostate cancer (CRPC). However, resistance to steroidal inhibitors inevitably develops in patients, the mechanisms of which remain largely unknown...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-2341

    authors: Xiao L,Wang Y,Xu K,Hu H,Xu Z,Wu D,Wang Z,You W,Ng CF,Yu S,Chan FL

    更新日期:2018-05-01 00:00:00

  • Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis.

    abstract::Polo-like kinase 1 (Plk1) is a key regulator of progression through mitosis. Although Plk1 seems to be dispensable for entry into mitosis, its role in spindle formation and exit from mitosis is crucial. Recent evidence suggests that a major role of Plk1 in exit from mitosis is the regulation of inhibitors of the anaph...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-06-0358

    authors: Eckerdt F,Strebhardt K

    更新日期:2006-07-15 00:00:00

  • Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells.

    abstract::It has been well established that overexpression of Cyclooxygenase-2 (Cox-2) in epithelial cells inhibits apoptosis and increases the invasiveness of malignant cells, favoring tumorigenesis and metastasis. However, the molecular mechanism that regulates Cox-2 expression has not been well defined in gastric carcinoma. ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Song SH,Jong HS,Choi HH,Inoue H,Tanabe T,Kim NK,Bang YJ

    更新日期:2001-06-01 00:00:00

  • Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

    abstract::Although the concept that cancers originate from stem cells (SC) is becoming scientifically accepted, mechanisms by which SC contribute to tumor initiation and progression are largely unknown. For colorectal cancer (CRC), investigation of this problem has been hindered by a paucity of specific markers for identificati...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-4418

    authors: Huang EH,Hynes MJ,Zhang T,Ginestier C,Dontu G,Appelman H,Fields JZ,Wicha MS,Boman BM

    更新日期:2009-04-15 00:00:00

  • Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.

    abstract::In the diagnosis of non-Hodgkin's lymphomas, the ready characterization of the neoplastic cell lineage by analysis of cell surface markers is of great importance. We present evidence for the existence of a human B-leukemia-associated antigen recognized by a complement-fixing monoclonal antibody (anti-Y 29/55). A hybri...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Forster HK,Gudat FG,Girard MF,Albrecht R,Schmidt J,Ludwig C,Obrecht JP

    更新日期:1982-05-01 00:00:00

  • Human alpha-lactalbumin made lethal to tumor cells (HAMLET) kills human glioblastoma cells in brain xenografts by an apoptosis-like mechanism and prolongs survival.

    abstract::Malignant brain tumors present a major therapeutic challenge because no selective or efficient treatment is available. Here, we demonstrate that intratumoral administration of human alpha-lactalbumin made lethal to tumor cells (HAMLET) prolongs survival in a human glioblastoma (GBM) xenograft model, by selective induc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.can-03-2661

    authors: Fischer W,Gustafsson L,Mossberg AK,Gronli J,Mork S,Bjerkvig R,Svanborg C

    更新日期:2004-03-15 00:00:00

  • Cytotoxic activity of immunotoxin SS1P is modulated by TACE-dependent mesothelin shedding.

    abstract::Mesothelin is a cell-surface tumor-associated antigen expressed in several human cancers. The limited expression of mesothelin on normal tissues and its high expression in many cancers make it an attractive candidate for targeted therapies using monoclonal antibodies, immunoconjugates, and immunotoxins. Mesothelin is ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-0466

    authors: Zhang Y,Chertov O,Zhang J,Hassan R,Pastan I

    更新日期:2011-09-01 00:00:00

  • Dynamic imaging of emerging resistance during cancer therapy.

    abstract::One of the greatest challenges in developing therapeutic regimens is the inability to rapidly and objectively assess tumor response due to treatment. Moreover, tumor response to therapeutic intervention in many cases is transient, and progressive alterations within the tumor may mask the effectiveness of an initially ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-3205

    authors: Lee KC,Hall DE,Hoff BA,Moffat BA,Sharma S,Chenevert TL,Meyer CR,Leopold WR,Johnson TD,Mazurchuk RV,Rehemtulla A,Ross BD

    更新日期:2006-05-01 00:00:00

  • Selective inhibition of human ribosomal gene transcription by the morpholinyl anthracyclines cyanomorpholinyl- and morpholinyldoxorubicin.

    abstract::Upon incubation of cultured mammalian cells with the new anthracycline analogues cyanomorpholinyldoxorubicin and morpholinyldoxorubicin, nucleoli irreversibly segregate into their substructures which form individual portions of the nucleolar mass and characteristic electron-dense components adjacent to the nucleolonem...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wassermann K,Newman RA,Davis FM,Mullins TD,Rose KM

    更新日期:1988-07-15 00:00:00

  • Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis.

    abstract::Fas (Apo-1/CD95) belongs to the tumor necrosis factor/nerve growth factor receptor family and transmits apoptotic signals by binding to its ligand. Interleukin-1beta-converting enzyme (ICE), which shows substantial homology to the product of the cell death gene, ced-3, of Caenorhabditis elegans, is reported to be invo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hasegawa J,Kamada S,Kamiike W,Shimizu S,Imazu T,Matsuda H,Tsujimoto Y

    更新日期:1996-04-15 00:00:00

  • Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression.

    abstract::In a previous study, we found that the small-molecule epidermal growth factor receptor (EGFR) inhibitor gefitinib (ZD1839, Iressa) blocked cell proliferation at biologically relevant concentrations in approximately one third (6 of 17) of human bladder cancer cell lines examined. Here, we studied the effects of gefitin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1224

    authors: Shrader M,Pino MS,Lashinger L,Bar-Eli M,Adam L,Dinney CP,McConkey DJ

    更新日期:2007-02-15 00:00:00

  • The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer.

    abstract::Invasion and metastasis are the hallmarks of malignant tumor progression and the main cause of death in cancer. The embryonic program "epithelial-mesenchymal transition" (EMT) is thought to trigger invasion by allowing tumor cell dissemination. Here, we describe that the EMT-inducing transcriptional repressor ZEB1 pro...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5682

    authors: Spaderna S,Schmalhofer O,Wahlbuhl M,Dimmler A,Bauer K,Sultan A,Hlubek F,Jung A,Strand D,Eger A,Kirchner T,Behrens J,Brabletz T

    更新日期:2008-01-15 00:00:00

  • Glutamine-Directed Migration of Cancer-Activated Fibroblasts Facilitates Epithelial Tumor Invasion.

    abstract::Tumors are complex tissues composed of transformed epithelial cells as well as cancer-activated fibroblasts (CAF) that facilitate epithelial tumor cell invasion. We show here that CAFs and other mesenchymal cells rely much more on glutamine than epithelial tumor cells; consequently, they are more sensitive to inhibiti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-20-0622

    authors: Mestre-Farrera A,Bruch-Oms M,Peña R,Rodríguez-Morató J,Alba-Castellón L,Comerma L,Quintela-Fandino M,Duñach M,Baulida J,Pozo ÓJ,García de Herreros A

    更新日期:2021-01-15 00:00:00

  • Ectopic expression of P-cadherin correlates with promoter hypomethylation early in colorectal carcinogenesis and enhanced intestinal crypt fission in vivo.

    abstract::P-cadherin is normally expressed in the basal layer of squamous epithelia and absent from the healthy intestine and colon. We have previously shown it to be expressed in all inflamed, hyperplastic, and dysplastic intestinal and colonic mucosa. This study aimed to better understand the mechanisms controlling the expres...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0020

    authors: Milicic A,Harrison LA,Goodlad RA,Hardy RG,Nicholson AM,Presz M,Sieber O,Santander S,Pringle JH,Mandir N,East P,Obszynska J,Sanders S,Piazuelo E,Shaw J,Harrison R,Tomlinson IP,McDonald SA,Wright NA,Jankowski JA

    更新日期:2008-10-01 00:00:00

  • Intragenic mutation analysis of the human epidermal growth factor receptor (EGFR) gene in malignant human oral keratinocytes.

    abstract::Alteration in epidermal growth factor receptor (EGFR) expression is frequently associated with malignant transformation of epithelial tissues, including oral mucosa. This study examines the mutations in the coding region of the human EGFR gene in normal and malignant human oral keratinocytes. To examine the intragenic...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shintani S,Matsuo K,Crohin CC,McBride J,Tsuji T,Donoff RB,Posner M,Todd R,Wong DT

    更新日期:1999-08-15 00:00:00

  • Flow cytometric analysis of pentakis(aziridino)thiatriazadiphosphorine oxide (SOAz)-induced changes in cell cycle progression of HeLa and HL-60 cells.

    abstract::The treatment of HeLa and HL-60 cells with various concentrations of pentakis(arizidino)thiatriazadiphosphorine oxide results in inhibition of growth and modification of cell cycle distribution. These phenomena were observed at 10(-4) M and 5 X 10(-5) M for HeLa cells and 10(-5) M and 5 X 10(-6) M for HL-60 cells. The...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hecquet C,Nafziger J,Ronot X,Marie JP,Adolphe M

    更新日期:1985-02-01 00:00:00

  • Estramustine depolymerizes microtubules by binding to tubulin.

    abstract::To investigate the mechanism of action of the antineoplastic drug estramustine, we compared its effects on human prostate cancer cells with those of vinblastine. At their respective concentrations that result in 50% inhibition of clonogenic growth, both drugs caused an accumulation of cells blocked at mitosis and simi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dahllöf B,Billström A,Cabral F,Hartley-Asp B

    更新日期:1993-10-01 00:00:00

  • Beyond DNA cross-linking: history and prospects of DNA-targeted cancer treatment--fifteenth Bruce F. Cain Memorial Award Lecture.

    abstract::The origin of cancer chemotherapy can be traced to the wartime discovery of the lymphotoxic action of nitrogen mustards. These and other bifunctional agents were later found to produce various types of DNA cross-links, and some of these agents continue to be mainstays of current therapy. The cellular pharmacology of t...

    journal_title:Cancer research

    pub_type: 历史文章

    doi:

    authors: Kohn KW

    更新日期:1996-12-15 00:00:00

  • Seasonal and geographical changes of spontaneous skin papillomas in the Japanese newt Cynops pyrrhogaster.

    abstract::The occurrence of spontaneous skin papillomas in Japanese newts (Cynops pyrrhogaster) from Niigata prefecture in Northern Japan was monitored over four seasons covering a period of 2 years. Of 13,613 newts, 249 were found to possess papillomas. The percentage of newts with papillomas was highest in autumn, ranging fro...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Asashima M,Komazaki S,Satou C,Oinuma T

    更新日期:1982-09-01 00:00:00

  • Maintenance of p53 alterations throughout breast cancer progression.

    abstract::Overexpression of the nuclear phosphoprotein p53 is one of the most common abnormalities in primary human cancer and appears to be due to point mutation within a highly conserved region of the p53 gene which then encodes for a mutant, more stable protein. In this study different stages of breast cancer progression wer...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Davidoff AM,Kerns BJ,Iglehart JD,Marks JR

    更新日期:1991-05-15 00:00:00

  • Cytokinetic and biochemical effects of 5-iminodaunorubicin in human colon carcinoma in culture.

    abstract::The semisynthetic anthracycline, 5-iminodaunorubicin (IM), was investigated to see whether modification of the benzoquinone moiety to produce a drug with low free radical potential would alter the cytotoxic and biochemical characteristics of this drug in comparison to Adriamycin (ADR), an agent with high free radical ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Glazer RI,Hartman KD,Richardson CL

    更新日期:1982-01-01 00:00:00

  • Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.

    abstract::Serological identification of tumor antigens by cDNA expression cloning is a technique used to isolate cDNAs encoding tumor antigens that are recognized by IgG antibodies in sera from cancer patients. It is also useful for the isolation of tumor antigens recognized by T cells. We applied this method to identify melano...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kiniwa Y,Fujita T,Akada M,Ito K,Shofuda T,Suzuki Y,Yamamoto A,Saida T,Kawakami Y

    更新日期:2001-11-01 00:00:00

  • Effects of the antitumor agent 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one on the DNA of mouse L1210 cells.

    abstract::L1210 murine leukemia cells were treated in vitro with the novel antineoplastic agent 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d] -1,2,3,5-tetrazin-4(3H)-one (M&B 39565), and its interaction with cellular DNA was assessed by alkaline elution. DNA interstrand cross-link and DNA-protein cross-link formation was quantifi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gibson NW,Erickson LC,Hickman JA

    更新日期:1984-05-01 00:00:00

  • Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.

    abstract::The phosphatidylinositol 3-kinase (PI3K) pathway regulates various cellular processes, including cellular proliferation and intracellular trafficking, and may affect prostate carcinogenesis. Thus, we explored the association between single-nucleotide polymorphisms (SNP) in PI3K genes and prostate cancer. Pooled data f...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-3575

    authors: Koutros S,Schumacher FR,Hayes RB,Ma J,Huang WY,Albanes D,Canzian F,Chanock SJ,Crawford ED,Diver WR,Feigelson HS,Giovanucci E,Haiman CA,Henderson BE,Hunter DJ,Kaaks R,Kolonel LN,Kraft P,Le Marchand L,Riboli E,Siddi

    更新日期:2010-03-15 00:00:00

  • Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death.

    abstract::Cancer cells often fail to respond to stimuli that normally activate their intrinsic apoptotic machinery. Moreover, they are able to adapt to hypoxia by changing their glycolytic rate. Pyruvate kinase (PK) is a rate-limiting enzyme in glycolysis that is converted to a less active dimer form of PKM2 isoenzyme during on...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-2870

    authors: Steták A,Veress R,Ovádi J,Csermely P,Kéri G,Ullrich A

    更新日期:2007-02-15 00:00:00

  • Sustained small interfering RNA delivery by mesoporous silicon particles.

    abstract::RNA interference (RNAi) is a powerful approach for silencing genes associated with a variety of pathologic conditions; however, in vivo RNAi delivery has remained a major challenge due to lack of safe, efficient, and sustained systemic delivery. Here, we report on a novel approach to overcome these limitations using a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-3931

    authors: Tanaka T,Mangala LS,Vivas-Mejia PE,Nieves-Alicea R,Mann AP,Mora E,Han HD,Shahzad MM,Liu X,Bhavane R,Gu J,Fakhoury JR,Chiappini C,Lu C,Matsuo K,Godin B,Stone RL,Nick AM,Lopez-Berestein G,Sood AK,Ferrari M

    更新日期:2010-05-01 00:00:00

  • Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker.

    abstract::Hypoxia in human tumors is associated with poor prognosis, but the molecular mechanisms underlying this association are poorly understood. One possibility is that hypoxia is linked to malignant progression through vascular endothelial growth factor (VEGF) induction and the associated angiogenesis and metastasis. The p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Raleigh JA,Calkins-Adams DP,Rinker LH,Ballenger CA,Weissler MC,Fowler WC Jr,Novotny DB,Varia MA

    更新日期:1998-09-01 00:00:00

  • Anastellin, a fragment of the first type III repeat of fibronectin, inhibits extracellular signal-regulated kinase and causes G(1) arrest in human microvessel endothelial cells.

    abstract::The formation of a microvascular endothelium plays a critical role in the growth and metastasis of established tumors. The ability of a fragment from the first type III repeat of fibronectin (III(1C)), anastellin, to suppress tumor growth and metastasis in vivo has been reported to be related to its antiangiogenic pro...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ambesi A,Klein RM,Pumiglia KM,McKeown-Longo PJ

    更新日期:2005-01-01 00:00:00